Carol A. Menard
Pfizer (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Neurogenetic and Muscular Disorders Research, RNA Research and Splicing, Click Chemistry and Applications, RNA modifications and cancer
Most-Cited Works
- → Rational Targeting of Active-Site Tyrosine Residues Using Sulfonyl Fluoride Probes(2015)191 cited
- → Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections(2012)97 cited
- → Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections(2011)97 cited
- → Thrombospondin and fibronectin are synthesized by neutrophils in human inflammatory joint disease and in a rabbit model of in vivo neutrophil activation.(1989)50 cited
- → Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents(2012)37 cited
- → Discovery of 3-Cyano- N -(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H -pyrrolo[2,3- b ]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist(2018)32 cited
- → Design of Potent mRNA Decapping Scavenger Enzyme (DcpS) Inhibitors with Improved Physicochemical Properties To Investigate the Mechanism of Therapeutic Benefit in Spinal Muscular Atrophy (SMA)(2017)20 cited
- → In vitro and in vivo effects of 2,4 diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS: Context-specific modulation of SMN transcript levels(2017)18 cited
- → A library approach to rapidly discover photoaffinity probes of the mRNA decapping scavenger enzyme DcpS(2015)13 cited